Nurse Practitioner in Hampton, IA Accepting Medicare
6 Nurse Practitioner nurses found. Showing 1 - 6
 Vanessa Jane Miller, ARNP Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 1720 Central Ave E Ste A, Hampton, IA 50441 Phone: 641-456-5050 |
Stacey Marie Arthur, APRN Nurse Practitioner - Women's Health Medicare: Medicare Enrolled Practice Location: 1720 Central Ave E, Hampton, IA 50441 Phone: 641-456-5000 |
Daphne K Landers, ARNP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 1720 Central Avenue East, Hampton, IA 50441 Phone: 641-456-5050 Fax: 641-456-5060 |
Amber Lee Campbell, APRN Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 700 2nd St Se Ste 101, Hampton, IA 50441 Phone: 641-812-1094 Fax: 641-812-1096 |
Carol J Kelly, ARNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1720 Central Ave E, Suite Fmc, Hampton, IA 50441 Phone: 641-456-5050 Fax: 641-456-5060 |
Emily Joan Melendez, ARNP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 1720 Central Ave E, Hampton, IA 50441 Phone: 641-456-5033 Fax: 641-456-5049 |
News Archive
Critically ill patients on antidepressants more likely to die
Researchers at Beth Israel Deaconess Medical Center, in Boston, and the Massachusetts Institute of Technology in Cambridge, have found that critically ill patients were more likely to die if they were taking the most commonly prescribed antidepressants when they were admitted to the intensive care unit (ICU).
UC baby health innovation wins Gates award
An innovative, colourful and accessible design to improve child health records worldwide has earned a University of Canberra graphic design lecturer a prestigious international award.
Protalix BioTherapeutics reports positive results from PRX-105 Phase I clinical trial
Protalix BioTherapeutics, Inc. announced today the completion of its phase I clinical trial of PRX-105, a plant cell expressed pegylated recombinant human acetylcholinesterase in development for biodefense indications. The trial established the pharmacokinetics of the protein and demonstrated that single dose, intravenous administration of PRX-105 is safe and well tolerated.
Idaho Technology receives USASMDC contract to develop flu tests for military personnel
Idaho Technology, Inc. has been awarded a contract by the U.S. Army Space and Missile Defense Command (USASMDC) to develop tests for multiple flu strains on the Joint Biological Agent Identification and Diagnostic System (JBAIDS).
› Verified 8 days ago